Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The new agreement comes at a time when GSK and CureVac have been at risk of falling behind in mRNA vaccines for respiratory diseases, with combined flu/COVID-19 candidates from Moderna and Pfizer ...

GSK said at an R&D update in the summer that it expects to have two mRNA candidates in clinical trials within 12 months and six within the next four years, including seasonal flu shots.

RSV vaccines respond to a significant unmet medical need,” GSK's spokesperson added on Wednesday. A Pfizer spokesperson reminded in an email that flu vaccines also have been associated with GBS.

Moderna, Pfizer, and a partnership between GSK and CureVac are reportedly working ... and Prevention reported the first death from bird flu on Monday, announcing an elderly patient with underlying ...

Bird flu has severely impacted poultry farms and ... Other players, including Pfizer and GSK (in collaboration with CureVac), are testing similar candidates. For investors who want to play the ...